These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36039485)
1. Differential effects of omega-3 PUFAS on tumor progression at early and advanced stages in TRAMP mice. Amaro GM; da Silva ADT; Tamarindo GH; Lamas CA; Taboga SR; Cagnon VHA; Góes RM Prostate; 2022 Dec; 82(16):1491-1504. PubMed ID: 36039485 [TBL] [Abstract][Full Text] [Related]
2. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Wang S; Wu J; Suburu J; Gu Z; Cai J; Axanova LS; Cramer SD; Thomas MJ; Perry DL; Edwards IJ; Mucci LA; Sinnott JA; Loda MF; Sui G; Berquin IM; Chen YQ Carcinogenesis; 2012 Feb; 33(2):404-12. PubMed ID: 22159221 [TBL] [Abstract][Full Text] [Related]
3. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice. Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105 [TBL] [Abstract][Full Text] [Related]
4. Androgen-independent prostate cancer progression in the TRAMP model. Gingrich JR; Barrios RJ; Kattan MW; Nahm HS; Finegold MJ; Greenberg NM Cancer Res; 1997 Nov; 57(21):4687-91. PubMed ID: 9354422 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase. Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891 [TBL] [Abstract][Full Text] [Related]
6. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP). da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383 [TBL] [Abstract][Full Text] [Related]
7. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice. Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351 [TBL] [Abstract][Full Text] [Related]
8. Dietary Long-Chain n-3 Polyunsaturated Fatty Acid Supplementation Alters Electrophysiological Properties in the Nucleus Accumbens and Emotional Behavior in Naïve and Chronically Stressed Mice. Di Miceli M; Martinat M; Rossitto M; Aubert A; Alashmali S; Bosch-Bouju C; Fioramonti X; Joffre C; Bazinet RP; Layé S Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743093 [TBL] [Abstract][Full Text] [Related]
10. Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Kelavkar UP; Hutzley J; Dhir R; Kim P; Allen KG; McHugh K Neoplasia; 2006 Feb; 8(2):112-24. PubMed ID: 16611404 [TBL] [Abstract][Full Text] [Related]
12. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508 [TBL] [Abstract][Full Text] [Related]
13. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes. Peek EM; Song W; Zhang H; Huang J; Chin AI Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486 [TBL] [Abstract][Full Text] [Related]
14. Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes. Kelavkar UP; Hutzley J; McHugh K; Allen KG; Parwani A Neoplasia; 2009 Jul; 11(7):692-9. PubMed ID: 19568414 [TBL] [Abstract][Full Text] [Related]
15. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Foster BA; Gingrich JR; Kwon ED; Madias C; Greenberg NM Cancer Res; 1997 Aug; 57(16):3325-30. PubMed ID: 9269988 [TBL] [Abstract][Full Text] [Related]
16. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches. Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182 [TBL] [Abstract][Full Text] [Related]
17. The ratio of n-6 to n-3 polyunsaturated fatty acids in the rat diet alters serum lipid levels and lymphocyte functions. Jeffery NM; Sanderson P; Sherrington EJ; Newsholme EA; Calder PC Lipids; 1996 Jul; 31(7):737-45. PubMed ID: 8827697 [TBL] [Abstract][Full Text] [Related]
19. Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Gupta S; Adhami VM; Subbarayan M; MacLennan GT; Lewin JS; Hafeli UO; Fu P; Mukhtar H Cancer Res; 2004 May; 64(9):3334-43. PubMed ID: 15126378 [TBL] [Abstract][Full Text] [Related]
20. A dietary tomato supplement prevents prostate cancer in TRAMP mice. Pannellini T; Iezzi M; Liberatore M; Sabatini F; Iacobelli S; Rossi C; Alberti S; Di Ilio C; Vitaglione P; Fogliano V; Piantelli M Cancer Prev Res (Phila); 2010 Oct; 3(10):1284-91. PubMed ID: 20716635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]